AVP and Recurrent lower respiratory tract infections: Besides the clinical indications mentioned so far, the role of copeptin as a prognostic biomarker was also examined in a variety of other indications, such as acute exacerbations of chronic obstructive pulmonary disease [34], lower respiratory tract infections [35], hemorrhagic and septic shock [15], stroke [36,37] and traumatic brain injury [38].